搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
红板报 on MSN
5 天
德琪医药希维奥第三项适应症在韩国获批上市,为韩国MM患者带来新选择
// 这是希维奥在韩国斩获的第三项适应症,用于治疗多发性骨髓瘤(MM)患者。 希维奥已在韩国、中国大陆、澳大利亚和新加坡实现医保收录,公司预计其将在亚太地区的更多市场获得医保收录。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
NK troops in RU confirmed
Linked to E. coli outbreak
Arlington visit records order
Dodgers legend dies
2 US troops injured in raid
Trespassing charge upheld
Veteran film producer dies
MO court upholds release
Arrested in trafficking case
Lake Erie toxic algae study
To close 150 locations
To appear on Rogan podcast
Funds corruption guilty plea
First father-son duo in NBA
FDA approves RSV vaccine
Giant ‘ghost’ fish spotted
DOJ alleges racial bias
GA election rules appeal
FAA finalizes safety rules
Brain stimulation study
2025 Medicare changes
SK mulls arms for Ukraine
Raises US growth forecast
Same-day pharmacy delivery
Six indicted for fraud in Ohio
US semiconductor tax credit
Infant mortality increased
Probing leak of US intel
Hospitals' IV fluid shortage
Ordered to hand over assets
Reveals 2025 tax brackets
反馈